| The role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in cardiovascular homeostasis: a non-systematic literature review A Hachem, E Hariri, P Saoud, C Lteif, L Lteif, F Welty Current cardiology reviews 13 (4), 274-282, 2017 | 27 | 2017 |
| Therapeutic challenges and emerging treatment targets for pulmonary hypertension in left heart disease C Lteif, A Ataya, JD Duarte Journal of the American Heart Association 10 (11), e020633, 2021 | 16 | 2021 |
| Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension MJ Arwood, N Vahabi, C Lteif, RK Sharma, RF Machado, JD Duarte Scientific Reports 9 (1), 19572, 2019 | 11 | 2019 |
| Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers LA Guerra, C Lteif, MJ Arwood, CW McDonough, L Dumeny, AA Desai, ... The pharmacogenomics journal 22 (1), 62-68, 2022 | 8 | 2022 |
| Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria N Chamoun, E Ramia, C Lteif, P Salameh, H Zantout, G Ghanem, ... Current Medical Research and Opinion 35 (3), 427-433, 2019 | 8 | 2019 |
| Transcatheter aortic valve implantation: acute and 6-month outcomes of the first Lebanese experience and a literature review E Hariri, A Hachem, N Chamoun, E Haddad, D Tamer, C Lteif, A Naja, ... LMJ-Lebanese Medical Journal 65 (1), 7-14, 2017 | 5 | 2017 |
| An introductory tutorial on cardiovascular pharmacogenetics for healthcare providers A Oni‐Orisan, S Tuteja, G Hoffecker, DM Smith, M Castrichini, KR Crews, ... Clinical Pharmacology & Therapeutics 114 (2), 275-287, 2023 | 3 | 2023 |
| Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment N Chamoun, H Ghanem, A Hachem, E Hariri, C Lteif, H Mansour, ... BMC Pharmacology and Toxicology 20, 1-9, 2019 | 3 | 2019 |
| Patients’ perspectives of factors that influence pharmacogenetic testing uptake: Enhancing patient counseling and results dissemination D Bagautdinova, C Lteif, E Eddy, J Terrell, CL Fisher, JD Duarte Journal of Personalized Medicine 12 (12), 2046, 2022 | 2 | 2022 |
| Beta-blocker dose stratifies mortality risk in a racially diverse heart failure population C Lteif, MJ Arwood, M Kansal, LH Cavallari, AA Desai, JD Duarte Journal of cardiovascular pharmacology 75 (3), 250-258, 2020 | 2 | 2020 |
| Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients C Lteif, E Eddy, J Terrell, LH Cavallari, J Malaty, JD Duarte Clinical and Translational Science 17 (1), e13692, 2024 | 1 | 2024 |
| Using Omics to Identify Novel Therapeutic Targets in Heart Failure C Lteif, Y Huang, LA Guerra, BE Gawronski, JD Duarte Circulation: Genomic and Precision Medicine, e004398, 2024 | | 2024 |
| Genome-Wide Association Study Identifies Polymorphisms Associated with Heart Failure Mortality in a Diverse Patient Population Y Huang, L Dumeny, G Yang, C Lteif, MJ Arwood, CW McDonough, ... Circulation 144 (Suppl_1), A10608-A10608, 2021 | | 2021 |
| MIRABEGRON IMPROVES RIGHT VENTRICULAR SYSTOLIC PRESSURE IN A PRE-CLINICAL MODEL OF PULMONARY HYPERTENSION DUE TO LEFT HEART FAILURE WITH PRESERVED EJECTION FRACTION. C Lteif, R Sharma, J Duarte CLINICAL PHARMACOLOGY & THERAPEUTICS 109, S46-S46, 2021 | | 2021 |
| THREE PRIME UTR VARIANTS IN ADRB3 ASSOCIATED WITH PULMONARY HYPERTENSION IN HEART FAILURE. C Lteif, J Duarte, R Dalton, C McDonough CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S89-S89, 2020 | | 2020 |
| ARTICLE ORIGINAL/ORIGINAL ARTICLE CM LTEIF, AS NAJA, GA SARKIS, GY GHANEM Lebanese Medical Journal 65 (1), 7, 2017 | | 2017 |
